| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 17/12/2024 | 22:33 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:SKIN | Beauth Health Company |
| 17/12/2024 | 22:30 | Business Wire | BeautyHealth Appoints Stephen J. Fanning to Board of Directors | NASDAQ:SKIN | Beauth Health Company |
| 11/12/2024 | 14:00 | Business Wire | BeautyHealth Releases 2024 Skintuition Report | NASDAQ:SKIN | Beauth Health Company |
| 21/11/2024 | 22:48 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:SKIN | Beauth Health Company |
| 14/11/2024 | 17:03 | Edgar (US Regulatory) | Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] | NASDAQ:SKIN | Beauth Health Company |
| 12/11/2024 | 23:22 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:SKIN | Beauth Health Company |
| 12/11/2024 | 22:05 | Business Wire | BeautyHealth Reports Third Quarter 2024 Financial Results | NASDAQ:SKIN | Beauth Health Company |
| 08/11/2024 | 14:00 | Business Wire | BeautyHealth to Report Third Quarter 2024 Financial Results on November 12, 2024 | NASDAQ:SKIN | Beauth Health Company |
| 17/10/2024 | 21:28 | Business Wire | Hydrafacial Announces Video Poster Abstract Presentation at the 2024 American Society for Dermatologic Surgery’s Annual Meeting (ASDS): Hydrafacial enhances the outcomes of non-ablative laser and IPL treatments | NASDAQ:SKIN | Beauth Health Company |
| 15/10/2024 | 22:10 | Business Wire | The Beauty Health Company Strengthens Commercial Leadership Team with Chief Revenue Officer and Chief Marketing Officer Appointments | NASDAQ:SKIN | Beauth Health Company |
| 15/10/2024 | 16:51 | Business Wire | Hydrafacial Announces Glow Getter Scholarship Program in Support of Estheticians | NASDAQ:SKIN | Beauth Health Company |
| 01/10/2024 | 14:00 | Business Wire | Hydrafacial Launches New Hydralock HA Booster with Clinically Proven Results | NASDAQ:SKIN | Beauth Health Company |
| 08/08/2024 | 22:05 | Business Wire | BeautyHealth Reports Second Quarter 2024 Financial Results | NASDAQ:SKIN | Beauth Health Company |
| 30/07/2024 | 14:00 | Business Wire | BeautyHealth to Report Second Quarter 2024 Financial Results on August 8, 2024 | NASDAQ:SKIN | Beauth Health Company |
| 17/05/2024 | 23:42 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial ownership by individuals | NASDAQ:SKIN | Beauth Health Company |
| 09/05/2024 | 22:05 | Business Wire | BeautyHealth Reports First Quarter 2024 Financial Results | NASDAQ:SKIN | Beauth Health Company |
| 26/04/2024 | 14:00 | Business Wire | BeautyHealth to Report First Quarter 2024 Financial Results on May 9, 2024 | NASDAQ:SKIN | Beauth Health Company |
| 09/04/2024 | 22:10 | Business Wire | BeautyHealth Names Sheri Lewis as Chief Supply Chain and Operations Officer | NASDAQ:SKIN | Beauth Health Company |
| 12/03/2024 | 21:10 | Business Wire | BeautyHealth Reports Full Year and Fourth Quarter 2023 Financial Results | NASDAQ:SKIN | Beauth Health Company |
| 12/03/2024 | 21:05 | Business Wire | BeautyHealth Announces Appointment Of Marla Beck As Chief Executive Officer | NASDAQ:SKIN | Beauth Health Company |
| 12/03/2024 | 12:22 | IH Market News | Global Markets Await U.S. Inflation Report: Mixed Movements in Pre-Market Trading | NASDAQ:SKIN | Beauth Health Company |
| 29/02/2024 | 22:28 | Edgar (US Regulatory) | Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | NASDAQ:SKIN | Beauth Health Company |
| 29/02/2024 | 22:06 | Business Wire | BeautyHealth To Now Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024 | NASDAQ:SKIN | Beauth Health Company |
| 27/02/2024 | 22:05 | Business Wire | BeautyHealth to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024 | NASDAQ:SKIN | Beauth Health Company |
| 12/01/2024 | 11:45 | PR Newswire (US) | SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of The Beauty Health Company of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 16, 2024 - (NASDAQ: SKIN) | NASDAQ:SKIN | Beauth Health Company |
| 14/12/2023 | 22:04 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] | NASDAQ:SKIN | Beauth Health Company |
| 12/12/2023 | 14:00 | Business Wire | BeautyHealth 2023 Skintuition Report: The Skin Health Trends and Data Shaping the Year | NASDAQ:SKIN | Beauth Health Company |
| 13/11/2023 | 22:17 | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB | NASDAQ:SKIN | Beauth Health Company |
| 13/11/2023 | 22:10 | Business Wire | BeautyHealth Reports Third Quarter 2023 Financial Results | NASDAQ:SKIN | Beauth Health Company |
| 13/11/2023 | 22:05 | Business Wire | BeautyHealth Announces Leadership Transition | NASDAQ:SKIN | Beauth Health Company |
